08.01.05 |
Formulary
|
 |
Atezolizumab injection urothelial cancer indications |
08.01.05 |
Formulary
|
 |
Avelumab injection renal cell carcinoma |
08.01.05 |
Formulary
|
 |
Axicabtagene ciloleucel cells dispersion for infusion |
08.01.05 |
Formulary
|
 |
Bevacizumab injection licensed use |
08.01.05 |
Formulary
|
 |
Larotrectinib oral solution |
08.01.05 |
Formulary
|
 |
Nivolumab injection haematological and lung cancer |
08.01.05 |
Formulary
|
 |
Nivolumab injection head and neck, renal and skin cancer |
08.01.05 |
Formulary
|
 |
Pembrolizumab injection lymphoma and lung cancer indications |
08.01.05 |
Formulary
|
 |
Pembrolizumab injection urothelial cancer indications |
08.01.05 |
Formulary
|
 |
Tisagenlecleucel cells dispersion for infusion |